Abilash Sathyanarayanan
Research Subjects
Abilash Sathyanarayanan has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Alfredo Petrosino
Centre for Kidney and Bladder Health and
1 shared publication Anthony Heagerty
Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
1 shared publication- Bhuvaneswari Krishnamurthy
Department of Pharmacology PSG Institute of Medical Sciences and Research Peelamedu, Coimbatore – 641004, Tamilnadu, India
1 shared publication Carmen Maniero
William Harvey Research Institute, Barts & The London School of Medicine & Dentistry, Queen Mary University of London, London, UK
1 shared publication- Eunice K.T. Phillips
Oxford University School of Medicine & Biomedical Sciences, University of Oxford, Oxford, UK
1 shared publication - Ian B. Wilkinson
Division of Experimental Medicine, University of Cambridge, Addenbrooke’s Hospital, Cambridge, UK
1 shared publication
Latest Publications
- Open Access
- 31 March 2026
- Published by Elsevier in Clinical Medicine
- Vol. 26 (3) , 100576
Renin–aldosterone testing: The essentials
- 31 March 2026
- Published by Elsevier in Clinical Medicine
- Vol. 26 (3) , 100576
Open AccessRenin–aldosterone testing: The essentials
- Open Access
- 9 December 2024
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 39 (1) , 1-14
Investigation and management of resistant hypertension: British and Irish Hypertension Society position statement
People living with resistant hypertension (RH) are at high risk of adverse cardiovascular events. The British and Irish Hypertension Society has identified suspected RH as a condition for which specialist guidance may improve rates of blood pressure control and help clinicians identify those individuals who may benefit from specialist review. In this position statement we provide a practical approach for the investigation and management of adults with RH. We highlight gaps in the current evidence and identify important future research questions. Our aim is to support the delivery of high-quality and consistent care to people living with RH across the UK and Ireland.
- 9 December 2024
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 39 (1) , 1-14
Open AccessInvestigation and management of resistant hypertension: British and Irish Hypertension Society position statement
People living with resistant hypertension (RH) are at high risk of adverse cardiovascular events. The British and Irish Hypertension Society has identified suspected RH as a condition for which specialist guidance may improve rates of blood pressure control and help clinicians identify those individuals who may benefit from specialist review. In this position statement we provide a practical approach for the investigation and management of adults with RH. We highlight gaps in the current evidence and identify important future research questions. Our aim is to support the delivery of high-quality and consistent care to people living with RH across the UK and Ireland.
- 10 July 2024
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 38 (8) , 620-623
First, a seat; then, an upgrade
The Sir Stanley Peart Essay Competition is an annual event run by the British and Irish Hypertension Society to encourage Early Career Researchers to continue the ethos of Sir Stanley Peart. Sir Stanley Peart was a clinician and clinical researcher who made a major contribution to our understanding of blood pressure regulation. He was the first to demonstrate the release of noradrenaline in response to sympathetic nerve stimulation. He was also the first to purify, and determine the structure of, angiotensin and he later isolated the enzyme, renin, and carried out many important investigations of the factors controlling its release in the body. This year, the essay topic was “Do we need new classes of antihypertensive drugs?”. In his prize-winning essay, "First, a seat; then, an upgrade", Dr Sathyanarayanan argues that we do not need new classes of antihypertensive drugs, instead we should focus our attention on addressing the factors that lead to high blood pressure in the first place and use our existing drug classes more effectively.
- 10 July 2024
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 38 (8) , 620-623
First, a seat; then, an upgrade
The Sir Stanley Peart Essay Competition is an annual event run by the British and Irish Hypertension Society to encourage Early Career Researchers to continue the ethos of Sir Stanley Peart. Sir Stanley Peart was a clinician and clinical researcher who made a major contribution to our understanding of blood pressure regulation. He was the first to demonstrate the release of noradrenaline in response to sympathetic nerve stimulation. He was also the first to purify, and determine the structure of, angiotensin and he later isolated the enzyme, renin, and carried out many important investigations of the factors controlling its release in the body. This year, the essay topic was “Do we need new classes of antihypertensive drugs?”. In his prize-winning essay, "First, a seat; then, an upgrade", Dr Sathyanarayanan argues that we do not need new classes of antihypertensive drugs, instead we should focus our attention on addressing the factors that lead to high blood pressure in the first place and use our existing drug classes more effectively.
- 2 April 2024
- Published by Taylor & Francis in Current Medical Research and Opinion
- Vol. 40 (5) , 887-892
The use of routinely collected healthcare records for outcome assessment in clinical trials: a UK perspective
IntroductionElectronic healthcare records (EHRs) came into use for practicing clinicians in the late 1980’s (1). Since then, the incorporation of EHRs in many healthcare systems has provided new op...
- 2 April 2024
- Published by Taylor & Francis in Current Medical Research and Opinion
- Vol. 40 (5) , 887-892
The use of routinely collected healthcare records for outcome assessment in clinical trials: a UK perspective
IntroductionElectronic healthcare records (EHRs) came into use for practicing clinicians in the late 1980’s (1). Since then, the incorporation of EHRs in many healthcare systems has provided new op...
- Open Access
- 1 January 2018
- Published by JCDR Research and Publications in Journal of Clinical and Diagnostic Research
- Vol. 12 (1) , FC5-FC8
Comparison of the Effects of Zonisamide and Flupirtine on Paclitaxel Induced Peripheral Neuropathy in Rats
- 1 January 2018
- Published by JCDR Research and Publications in Journal of Clinical and Diagnostic Research
- Vol. 12 (1) , FC5-FC8
Open AccessComparison of the Effects of Zonisamide and Flupirtine on Paclitaxel Induced Peripheral Neuropathy in Rats